Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alirocumab (C10Ax14) Within The Framework Of A So-Called Open-House Model.

AOK RHEINLAND-PFALZ SAARLAND - DIE GESUNDHEITSKASSE Germany has Released a tender for Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alirocumab (C10Ax14) Within The Framework Of A So-Called Open-House Model. in . The tender was released on Jun 12, 2024.

Country - Germany

Summary - Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alirocumab (C10Ax14) Within The Framework Of A So-Called Open-House Model.

Deadline - May 31, 2026

MT reference number - 82862117

Product classification - Food, beverages, tobacco and related products

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  MT Ref Id - 82862117

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Alirocumab (C10Ax14) Within The Framework Of A So-Called Open-House Model .local title:: Abschluss nicht exklusiver Rabattverträge gemäß §§ 130a Abs. 8/130c Abs. 1 SGB V zu Arzneimitteln mit dem Wirkstoff Alirocumab (C10AX14) im Rahmen eines sogenannten Open-House-Modells.

Mt Ref Id - 82862117

Deadline - May 31, 2026

Share

Similar Tenders :